American Portfolios Advisors Fate Therapeutics Inc Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Fate Therapeutics Inc stock. As of the latest transaction made, American Portfolios Advisors holds 2,985 shares of FATE stock, worth $5,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,985
Holding current value
$5,104
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$21.04 - $36.06 $62,804 - $107,639
2,985 New
2,985 $66.9 Million
Q2 2022

Mar 20, 2023
SELL
$17.78 - $42.39 $6,934 - $16,532
-390 Reduced 13.07%
2,595 $64.3 Million
Q1 2022

Mar 21, 2023
SELL
$29.67 - $60.28 $37,384 - $75,952
-1,260 Reduced 42.21%
1,725 $66.9 Million
Q4 2021

Mar 21, 2023
SELL
$47.84 - $64.34 $115,055 - $154,737
-2,405 Reduced 80.57%
580 $33.9 Million
Q3 2021

Mar 22, 2023
SELL
$59.27 - $95.73 $138,099 - $223,050
-2,330 Reduced 78.06%
655 $38.8 Million
Q2 2021

Mar 22, 2023
SELL
$67.25 - $92.52 $195,697 - $269,233
-2,910 Reduced 97.49%
75 $6.51 Million
Q3 2020

Mar 22, 2023
SELL
$30.41 - $40.5 $48,199 - $64,192
-1,585 Reduced 53.1%
1,400 $56 Million
Q2 2020

Mar 24, 2023
SELL
$20.21 - $35.23 $37,085 - $64,647
-1,835 Reduced 61.47%
1,150 $39.5 Million

Others Institutions Holding FATE

# of Institutions
167
Shares Held
101M
Call Options Held
41.3K
Put Options Held
15.9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $166M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email